Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06467123 · ClinicalTrials.gov registry record · NA

A Pilot Study Comparing Two Rehabilitation Approaches for Individuals With Irritable Shoulder Pain

A NA study of Shoulder Pain, sponsored by University of Central Florida.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT06467123 is a NA study of Shoulder Pain that has completed, run by University of Central Florida. The registered enrollment target is 24 participants, below the 100-participant average among 27 other Shoulder Pain trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06467123, a NA study of Shoulder Pain, has completed, sponsored by University of Central Florida.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

This pilot study will assess feasibility and obtain preliminary effects of a tissue based intervention to a biopsychosocial intervention in individuals with shoulder pain.

Conditions Studied

Interventions

  • OTHER Tissue Intervention
  • OTHER Biopsychosocial Intervention

Study Locations (1)

Florida

  • University of Central Florida - Orlando

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2024-06-28
Est. Completion 2025-02-28
Phase NA

Sponsor

University of Central Florida

91 total trials

What the Registry Record Tells You About NCT06467123

The ClinicalTrials.gov registry entry for NCT06467123 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 100-participant average among 27 other Shoulder Pain trials with a reported enrollment target (76% lower). The listed sponsor is University of Central Florida, which has 91 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Shoulder Pain appearing as the primary indexed condition, and to 2 interventions - of which Tissue Intervention is the first listed.

NCT06467123 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06467123 about?

NCT06467123 is a clinical study titled "A Pilot Study Comparing Two Rehabilitation Approaches for Individuals With Irritable Shoulder Pain". This pilot study will assess feasibility and obtain preliminary effects of a tissue based intervention to a biopsychosocial intervention in individuals with shoulder pain.

What is the current status of trial NCT06467123?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2024-06-28. Estimated completion is 2025-02-28.

What conditions does trial NCT06467123 study?

This clinical trial studies the following conditions: Shoulder Pain.

What interventions are being tested in trial NCT06467123?

The interventions under investigation include: Tissue Intervention (OTHER), Biopsychosocial Intervention (OTHER).

Who is sponsoring clinical trial NCT06467123?

This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06467123 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Shoulder Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.